Advertisement
Skip to Content

Surmodics Inc SRDX Stock Quote

| Rating as of

NASDAQ: SRDX

Last close prices updated as of Feb 02, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 28.47
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Small Blend
  • Day Range 28.66  –  30.19
  • Year Range 24.60  –  45.85
  • Market Cap 423.2133 Mil
  • Volume / Avg 49,884.0 /  47,650.6
  • Price / Sales 3.96
  • Price / Book 3.71
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis SRDX

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SRDX

Company Profile SRDX

Business Description

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Vitro diagnostics segment.

Contact
9924 West 74th Street
Eden Prairie, MN, 55344
Industry Medical Devices
Employees 447

FAQs for Surmodics Inc Stock

No. SRDX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SRDX’s market cap is 423.21 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SRDX’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

SRDX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SRDX’s historical performance against its industry peers and the overall market.